From our previous study, it was demonstrated that silencing of SND1 might result in the increased sensitivity of NSCLC to chemotherapeutic agents by promoting apoptosis via upregulating the level of PDCD4 [20]. The gene discussed is PDCD4; the disease is non-small cell lung carcinoma.